Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Hepatitis
4.2.2 Introduction of Molecular Diagnostics for the Diagnosis of Hepatitis
4.2.3 Increasing Awareness Regarding The Disease
4.3 Market Restraints
4.3.1 Limited Facilities or Services For Hepatitis Testing
4.3.2 Limited Access to Reliable and Low-Cost HBV and HCV Diagnostics
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Test Type
5.1.1 Blood Tests
5.1.1.1 Liver Function Tests
5.1.1.2 Immunoassays
5.1.1.3 Nucleic Acid Tests
5.1.2 Imaging Test
5.1.3 Liver Biopsy
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle-East and Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle-East and Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Danaher Corporation (Beckman Coulter Inc)
6.1.3 BioMerieux SA
6.1.4 Bio-Rad Laboratories Inc
6.1.5 Diasorin S.p.A
6.1.6 F. Hoffmann-La Roche AG
6.1.7 Hologic Inc
6.1.8 MedMira Inc
6.1.9 Qaigen Inc
6.1.10 Siemens Healthineers


7 MARKET OPPORTUNITIES AND FUTURE TRENDS